- Home
- REXR vs CORT Comparison
REXR vs CORT Comparison
Compare REXR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REXR | CORT |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | United States | United States |
| Employees | 256 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 3.7B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | REXR | CORT |
|---|---|---|
| Price | $35.49 | $69.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 5 |
| Target Price | $41.00 | ★ $96.50 |
| AVG Volume (30 Days) | ★ 1.6M | 1.2M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.90% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $761,407,000.00 |
| Revenue This Year | $0.09 | $26.08 |
| Revenue Next Year | $2.99 | $26.98 |
| P/E Ratio | $43.28 | ★ N/A |
| Revenue Growth | N/A | ★ 12.79 |
| 52 Week Low | $32.14 | $28.66 |
| 52 Week High | $44.38 | $91.00 |
Technical Indicators
Market Signals| Indicator | REXR | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 48.35 | 84.33 |
| Support Level | $34.75 | $68.20 |
| Resistance Level | $36.59 | $90.00 |
| Average True Range (ATR) | 0.66 | 2.46 |
| MACD | -0.02 | 1.04 |
| Stochastic Oscillator | 44.16 | 97.25 |
Price Performance
Historical ComparisonAbout REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust focused on owning, operating and acquiring industrial properties in Southern California infill markets. Its goal is to generate attractive risk-adjusted returns for the stockholders by providing superior access to industrial property investments and mortgage debt investments secured by industrial property in high-barrier Southern California infill markets. The company generates revenue from rental income derived from properties in its portfolio.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.